DMUC5754A
DMUC5754A Uses, Dosage, Side Effects, Food Interaction and all others data.
DMUC5754A is under investigation in clinical trial NCT01335958 (Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer).
| Trade Name | DMUC5754A |
| Generic | Sofituzumab vedotin |
| Sofituzumab vedotin Other Names | DMUC5754A, Sofituzumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here DMUC5754A
